BARDA T2 Biosystems Q1 Revenues Nearly Triple Product revenues were up 345 percent, as the firm increased US sepsis test utilization by 85 percent and sold four T2Dx instruments. TGen, Jumpcode Genomics Marrying NGS, CRISPR to Build a Better COVID-19 Test Premium As diagnostics firms develop a new wave of COVID-19 tests using next-gen sequencing, TGen researchers are also adding CRISPR-based sample prep to their kit. Federal Agencies Collaborate to Solicit Proposals for SARS-CoV-2 Testing Supply Chain Scale-up The collaborators are requesting submissions including budget proposals to scale all supporting components of diagnostic test manufacturing. Cue Health Ramping Up COVID-19 Test Production Following Positive Mayo Clinic Study, DoD Funding Premium The test uses isothermal nucleic acid amplification to return results in 20 minutes at the point of care, and demonstrated 98 percent agreement with PCR testing. Visby Medical Wins $12.3M BARDA Contract for Coronavirus, Flu Combo Test The test, a version of the company's rapid SARS-CoV-2 assay, will be designed for both point-of-care and at-home use as an over-the-counter product. Jan 13, 2021 BARDA Provides Additional Funding to DiaSorin Molecular for COVID-19 Tests Nov 18, 2020 FDA Grants Emergency Use Authorization to First At-Home COVID-19 Test From Lucira Health Nov 6, 2020 Mesa Biotech Awarded $13M in BARDA Funding for Coronavirus, Flu Combo Test Nov 2, 2020 Hologic Wins $119M Contract From US Government to Expand COVID-19 Test Capacity Oct 6, 2020 RAD-X Awards Six Phase 2 Contracts for COVID-19 Testing Sep 30, 2020 BARDA Exercises $10.5M Option on T2 Bio Contract Sep 24, 2020 BARDA Awards $5.4M to Luminex for Expanded Respiratory Panel With Coronavirus Target Sep 14, 2020 GenMark Diagnostics Receives CE Mark for Respiratory Panel Including SARS-CoV-2, Flu Sep 8, 2020 As Flu Season Nears, Dx Companies Shift Attention to Multiplex Tests for SARS-CoV-2, Influenza Premium Sep 1, 2020 Immunexpress, Biocartis to Roll Out Sepsis Test in Europe Ahead of Planned US Launch Premium Aug 5, 2020 Visby Medical Gonorrhea Test Wins $19M AMR Diagnostic Competition Jun 16, 2020 Immunexpress Nabs $599K BARDA Contract to Develop Sepsis Test for Coronavirus Patient Triage May 5, 2020 Tangen Biosciences Receives Additional $3.3M From BARDA May 4, 2020 Hologic Awarded $13M from BARDA to Develop Second Coronavirus Assay Apr 27, 2020 Merck, ISB Collaborating on COVID-19 Drug, Vaccine Target Discovery Apr 20, 2020 Tangen Biosciences Wins $696K BARDA Contract to Develop Point-of-Care Coronavirus MDx Test Apr 20, 2020 Vela Diagnostics Awarded BARDA Funding for COVID-19 Test Mar 31, 2020 Cue Health Awarded $13M BARDA Contract for POC Coronavirus Test Mar 31, 2020 Luminex Receives Second BARDA Contract for $642K to Develop Rapid SARS-CoV-2 Test Mar 23, 2020 GenMark Awarded $749K BARDA Grant for Development of Coronavirus Respiratory Panel Load More Breaking News Saga Diagnostics, University College London Cancer Institute Widen Cancer Collaboration New ALS Risk Gene Suggests Role for Apoptosis Weill Cornell Medicine Launches $1.5B Program to Advance Medical Research Danaher to Acquire Aldevron for $9.6B OncoDNA, Institut Jules Bordet Partner on Central Nervous System Metastasis Study Sequencing Study Uncovers MERS-Related Coronavirus in Swiss Bats The Scan Not as High as Hoped The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19. Finding Freshwater DNA A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports. Rise in Payments Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws. Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.